ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,720, issued on Feb. 10, was assigned to UCB BIOPHARMA SRL (Brussels).
"Anti-alpha-synuclein antibodies" was invented by Ralph Adams (Slough, Great Britain), Patrick Downey (Brussels), Terence Seward Baker (Slough, Great Britain), Kerry Louise Tyson (Slough, Great Britain), Lorenzo De Lichtervelde (Brussels), Daniel John Lightwood (Slough, Great Britain) and David James Mcmillan (Slough, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies binding alpha synuclein and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by...